EP0920521A1 - IDENTIFICATION ET CLONAGE D'UN TRANSPOSON MOBILE ISSU D'$i(ASPERGILLUS) - Google Patents
IDENTIFICATION ET CLONAGE D'UN TRANSPOSON MOBILE ISSU D'$i(ASPERGILLUS)Info
- Publication number
- EP0920521A1 EP0920521A1 EP97939558A EP97939558A EP0920521A1 EP 0920521 A1 EP0920521 A1 EP 0920521A1 EP 97939558 A EP97939558 A EP 97939558A EP 97939558 A EP97939558 A EP 97939558A EP 0920521 A1 EP0920521 A1 EP 0920521A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- dna
- gene
- vader
- transposable element
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 241000228212 Aspergillus Species 0.000 title abstract description 9
- 238000010367 cloning Methods 0.000 title description 12
- VJYFKVYYMZPMAB-UHFFFAOYSA-N ethoprophos Chemical compound CCCSP(=O)(OCC)SCCC VJYFKVYYMZPMAB-UHFFFAOYSA-N 0.000 title description 2
- 239000012634 fragment Substances 0.000 claims abstract description 48
- 239000000523 sample Substances 0.000 claims abstract description 45
- 241000233866 Fungi Species 0.000 claims abstract description 23
- 108090000623 proteins and genes Proteins 0.000 claims description 101
- 108020004414 DNA Proteins 0.000 claims description 92
- 239000003550 marker Substances 0.000 claims description 33
- 241001513093 Aspergillus awamori Species 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 26
- 102000008579 Transposases Human genes 0.000 claims description 20
- 108010020764 Transposases Proteins 0.000 claims description 20
- 230000014509 gene expression Effects 0.000 claims description 15
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 12
- 108700005075 Regulator Genes Proteins 0.000 claims description 9
- 230000004913 activation Effects 0.000 claims description 9
- 238000011144 upstream manufacturing Methods 0.000 claims description 9
- 238000012408 PCR amplification Methods 0.000 claims description 8
- 230000002068 genetic effect Effects 0.000 claims description 6
- 240000006439 Aspergillus oryzae Species 0.000 claims description 5
- 230000002950 deficient Effects 0.000 claims description 3
- 230000000415 inactivating effect Effects 0.000 claims description 3
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 2
- 108020000949 Fungal DNA Proteins 0.000 claims 5
- 230000001131 transforming effect Effects 0.000 claims 4
- 230000003213 activating effect Effects 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 1
- 101100264022 Drosophila melanogaster wgn gene Proteins 0.000 description 113
- 101150095344 niaD gene Proteins 0.000 description 81
- 244000117054 Rungia klossii Species 0.000 description 50
- 235000002492 Rungia klossii Nutrition 0.000 description 50
- 238000003780 insertion Methods 0.000 description 33
- 230000037431 insertion Effects 0.000 description 32
- 108700026244 Open Reading Frames Proteins 0.000 description 24
- 238000004458 analytical method Methods 0.000 description 24
- 238000009396 hybridization Methods 0.000 description 23
- 241000351920 Aspergillus nidulans Species 0.000 description 18
- 101000802053 Homo sapiens THUMP domain-containing protein 1 Proteins 0.000 description 18
- 102100034704 THUMP domain-containing protein 1 Human genes 0.000 description 18
- 230000000694 effects Effects 0.000 description 17
- 108020004707 nucleic acids Proteins 0.000 description 16
- 102000039446 nucleic acids Human genes 0.000 description 16
- 150000007523 nucleic acids Chemical class 0.000 description 16
- 108090000913 Nitrate Reductases Proteins 0.000 description 13
- 150000001413 amino acids Chemical group 0.000 description 13
- 101100298225 Caenorhabditis elegans pot-2 gene Proteins 0.000 description 12
- XTEGARKTQYYJKE-UHFFFAOYSA-M Chlorate Chemical compound [O-]Cl(=O)=O XTEGARKTQYYJKE-UHFFFAOYSA-M 0.000 description 12
- 241000228245 Aspergillus niger Species 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 229910002651 NO3 Inorganic materials 0.000 description 10
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 10
- 238000002105 Southern blotting Methods 0.000 description 10
- 239000002773 nucleotide Substances 0.000 description 10
- 125000003729 nucleotide group Chemical group 0.000 description 10
- 241001344131 Magnaporthe grisea Species 0.000 description 9
- 235000001014 amino acid Nutrition 0.000 description 9
- 238000002955 isolation Methods 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 8
- 101100536362 Rattus norvegicus Taok1 gene Proteins 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 108090000746 Chymosin Proteins 0.000 description 6
- 241000223221 Fusarium oxysporum Species 0.000 description 6
- RCYUBVHMVUHEBM-RCWTZXSCSA-N Pro-Pro-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RCYUBVHMVUHEBM-RCWTZXSCSA-N 0.000 description 6
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 6
- 238000001514 detection method Methods 0.000 description 6
- 230000002538 fungal effect Effects 0.000 description 6
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 6
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 6
- 241000363521 Acrocephalus cinnamomeus Species 0.000 description 5
- 241000892910 Aspergillus foetidus Species 0.000 description 5
- 241000228251 Aspergillus phoenicis Species 0.000 description 5
- SHIBSTMRCDJXLN-UHFFFAOYSA-N Digoxigenin Natural products C1CC(C2C(C3(C)CCC(O)CC3CC2)CC2O)(O)C2(C)C1C1=CC(=O)OC1 SHIBSTMRCDJXLN-UHFFFAOYSA-N 0.000 description 5
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 5
- 230000003321 amplification Effects 0.000 description 5
- 229940080701 chymosin Drugs 0.000 description 5
- QONQRTHLHBTMGP-UHFFFAOYSA-N digitoxigenin Natural products CC12CCC(C3(CCC(O)CC3CC3)C)C3C11OC1CC2C1=CC(=O)OC1 QONQRTHLHBTMGP-UHFFFAOYSA-N 0.000 description 5
- SHIBSTMRCDJXLN-KCZCNTNESA-N digoxigenin Chemical compound C1([C@@H]2[C@@]3([C@@](CC2)(O)[C@H]2[C@@H]([C@@]4(C)CC[C@H](O)C[C@H]4CC2)C[C@H]3O)C)=CC(=O)OC1 SHIBSTMRCDJXLN-KCZCNTNESA-N 0.000 description 5
- 238000002372 labelling Methods 0.000 description 5
- 230000035772 mutation Effects 0.000 description 5
- GNOLWGAJQVLBSM-UHFFFAOYSA-N n,n,5,7-tetramethyl-1,2,3,4-tetrahydronaphthalen-1-amine Chemical compound C1=C(C)C=C2C(N(C)C)CCCC2=C1C GNOLWGAJQVLBSM-UHFFFAOYSA-N 0.000 description 5
- 238000003199 nucleic acid amplification method Methods 0.000 description 5
- 230000002269 spontaneous effect Effects 0.000 description 5
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
- 241000228260 Aspergillus wentii Species 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- LZEUDRYSAZAJIO-AUTRQRHGSA-N Glu-Val-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LZEUDRYSAZAJIO-AUTRQRHGSA-N 0.000 description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 4
- 241000221961 Neurospora crassa Species 0.000 description 4
- OJRNZRROAIAHDL-LKXGYXEUSA-N Thr-Asn-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O OJRNZRROAIAHDL-LKXGYXEUSA-N 0.000 description 4
- KPMIQCXJDVKWKO-IFFSRLJSSA-N Thr-Val-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KPMIQCXJDVKWKO-IFFSRLJSSA-N 0.000 description 4
- LVFZXRQQQDTBQH-IRIUXVKKSA-N Tyr-Thr-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O LVFZXRQQQDTBQH-IRIUXVKKSA-N 0.000 description 4
- 108010062796 arginyllysine Proteins 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 125000001475 halogen functional group Chemical group 0.000 description 4
- 230000002779 inactivation Effects 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 238000002703 mutagenesis Methods 0.000 description 4
- 231100000350 mutagenesis Toxicity 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 230000008520 organization Effects 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 230000014616 translation Effects 0.000 description 4
- 241000203233 Aspergillus versicolor Species 0.000 description 3
- 101100298222 Caenorhabditis elegans pot-1 gene Proteins 0.000 description 3
- 108020004705 Codon Proteins 0.000 description 3
- 108010073178 Glucan 1,4-alpha-Glucosidase Proteins 0.000 description 3
- 102100022624 Glucoamylase Human genes 0.000 description 3
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 3
- BRPKEERLGYNCNC-NHCYSSNCSA-N Val-Glu-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N BRPKEERLGYNCNC-NHCYSSNCSA-N 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000006151 minimal media Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 230000017105 transposition Effects 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- ITZMJCSORYKOSI-AJNGGQMLSA-N APGPR Enterostatin Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)CCC1 ITZMJCSORYKOSI-AJNGGQMLSA-N 0.000 description 2
- IMMKUCQIKKXKNP-DCAQKATOSA-N Ala-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCN=C(N)N IMMKUCQIKKXKNP-DCAQKATOSA-N 0.000 description 2
- JAMAWBXXKFGFGX-KZVJFYERSA-N Ala-Arg-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JAMAWBXXKFGFGX-KZVJFYERSA-N 0.000 description 2
- PJNSIUPOXFBHDM-GUBZILKMSA-N Ala-Arg-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O PJNSIUPOXFBHDM-GUBZILKMSA-N 0.000 description 2
- CBCCCLMNOBLBSC-XVYDVKMFSA-N Ala-His-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O CBCCCLMNOBLBSC-XVYDVKMFSA-N 0.000 description 2
- OMDNCNKNEGFOMM-BQBZGAKWSA-N Ala-Met-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)NCC(O)=O OMDNCNKNEGFOMM-BQBZGAKWSA-N 0.000 description 2
- OLVCTPPSXNRGKV-GUBZILKMSA-N Ala-Pro-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OLVCTPPSXNRGKV-GUBZILKMSA-N 0.000 description 2
- NHWYNIZWLJYZAG-XVYDVKMFSA-N Ala-Ser-His Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N NHWYNIZWLJYZAG-XVYDVKMFSA-N 0.000 description 2
- NZGRHTKZFSVPAN-BIIVOSGPSA-N Ala-Ser-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N NZGRHTKZFSVPAN-BIIVOSGPSA-N 0.000 description 2
- CREYEAPXISDKSB-FQPOAREZSA-N Ala-Thr-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CREYEAPXISDKSB-FQPOAREZSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- WVRUNFYJIHNFKD-WDSKDSINSA-N Arg-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N WVRUNFYJIHNFKD-WDSKDSINSA-N 0.000 description 2
- KWKQGHSSNHPGOW-BQBZGAKWSA-N Arg-Ala-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)NCC(O)=O KWKQGHSSNHPGOW-BQBZGAKWSA-N 0.000 description 2
- OTOXOKCIIQLMFH-KZVJFYERSA-N Arg-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N OTOXOKCIIQLMFH-KZVJFYERSA-N 0.000 description 2
- NABSCJGZKWSNHX-RCWTZXSCSA-N Arg-Arg-Thr Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H]([C@H](O)C)C(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N NABSCJGZKWSNHX-RCWTZXSCSA-N 0.000 description 2
- JVMKBJNSRZWDBO-FXQIFTODSA-N Arg-Cys-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O JVMKBJNSRZWDBO-FXQIFTODSA-N 0.000 description 2
- HPKSHFSEXICTLI-CIUDSAMLSA-N Arg-Glu-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O HPKSHFSEXICTLI-CIUDSAMLSA-N 0.000 description 2
- PHHRSPBBQUFULD-UWVGGRQHSA-N Arg-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N PHHRSPBBQUFULD-UWVGGRQHSA-N 0.000 description 2
- ATABBWFGOHKROJ-GUBZILKMSA-N Arg-Pro-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O ATABBWFGOHKROJ-GUBZILKMSA-N 0.000 description 2
- AMIQZQAAYGYKOP-FXQIFTODSA-N Arg-Ser-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O AMIQZQAAYGYKOP-FXQIFTODSA-N 0.000 description 2
- LJUOLNXOWSWGKF-ACZMJKKPSA-N Asn-Asn-Glu Chemical compound C(CC(=O)O)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N LJUOLNXOWSWGKF-ACZMJKKPSA-N 0.000 description 2
- BHQQRVARKXWXPP-ACZMJKKPSA-N Asn-Asp-Glu Chemical compound C(CC(=O)O)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N BHQQRVARKXWXPP-ACZMJKKPSA-N 0.000 description 2
- FJIRXKVEDFLLOQ-SRVKXCTJSA-N Asn-Cys-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N)N FJIRXKVEDFLLOQ-SRVKXCTJSA-N 0.000 description 2
- IPPFAOCLQSGHJV-WFBYXXMGSA-N Asn-Trp-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(O)=O IPPFAOCLQSGHJV-WFBYXXMGSA-N 0.000 description 2
- GWTLRDMPMJCNMH-WHFBIAKZSA-N Asp-Asn-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O GWTLRDMPMJCNMH-WHFBIAKZSA-N 0.000 description 2
- ZSVJVIOVABDTTL-YUMQZZPRSA-N Asp-Gly-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)O)N ZSVJVIOVABDTTL-YUMQZZPRSA-N 0.000 description 2
- UZFHNLYQWMGUHU-DCAQKATOSA-N Asp-Lys-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O UZFHNLYQWMGUHU-DCAQKATOSA-N 0.000 description 2
- SARSTIZOZFBDOM-FXQIFTODSA-N Asp-Met-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(O)=O SARSTIZOZFBDOM-FXQIFTODSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- NOCCABSVTRONIN-CIUDSAMLSA-N Cys-Ala-Leu Chemical compound C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CS)N NOCCABSVTRONIN-CIUDSAMLSA-N 0.000 description 2
- MKVKKORBPTUSNX-LPEHRKFASA-N Cys-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CS)N MKVKKORBPTUSNX-LPEHRKFASA-N 0.000 description 2
- WZJLBUPPZRZNTO-CIUDSAMLSA-N Cys-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CS)N WZJLBUPPZRZNTO-CIUDSAMLSA-N 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- VSLCIGXQLCYQTD-NPJQDHAYSA-N Dynorphin B (10-13) Chemical compound NCCCC[C@@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@@H]([C@H](C)O)C(O)=O VSLCIGXQLCYQTD-NPJQDHAYSA-N 0.000 description 2
- JZDHUJAFXGNDSB-WHFBIAKZSA-N Glu-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O JZDHUJAFXGNDSB-WHFBIAKZSA-N 0.000 description 2
- AKJRHDMTEJXTPV-ACZMJKKPSA-N Glu-Asn-Ala Chemical compound C[C@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O AKJRHDMTEJXTPV-ACZMJKKPSA-N 0.000 description 2
- YYOBUPFZLKQUAX-FXQIFTODSA-N Glu-Asn-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YYOBUPFZLKQUAX-FXQIFTODSA-N 0.000 description 2
- CKOFNWCLWRYUHK-XHNCKOQMSA-N Glu-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O CKOFNWCLWRYUHK-XHNCKOQMSA-N 0.000 description 2
- PABVKUJVLNMOJP-WHFBIAKZSA-N Glu-Cys Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CS)C(O)=O PABVKUJVLNMOJP-WHFBIAKZSA-N 0.000 description 2
- IQACOVZVOMVILH-FXQIFTODSA-N Glu-Glu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O IQACOVZVOMVILH-FXQIFTODSA-N 0.000 description 2
- VSRCAOIHMGCIJK-SRVKXCTJSA-N Glu-Leu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VSRCAOIHMGCIJK-SRVKXCTJSA-N 0.000 description 2
- LHIPZASLKPYDPI-AVGNSLFASA-N Glu-Phe-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O LHIPZASLKPYDPI-AVGNSLFASA-N 0.000 description 2
- HAGKYCXGTRUUFI-RYUDHWBXSA-N Glu-Tyr-Gly Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CCC(=O)O)N)O HAGKYCXGTRUUFI-RYUDHWBXSA-N 0.000 description 2
- SITLTJHOQZFJGG-XPUUQOCRSA-N Glu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](N)CCC(O)=O SITLTJHOQZFJGG-XPUUQOCRSA-N 0.000 description 2
- QXUPRMQJDWJDFR-NRPADANISA-N Glu-Val-Ser Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O QXUPRMQJDWJDFR-NRPADANISA-N 0.000 description 2
- 102000053187 Glucuronidase Human genes 0.000 description 2
- 108010060309 Glucuronidase Proteins 0.000 description 2
- LJPIRKICOISLKN-WHFBIAKZSA-N Gly-Ala-Ser Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O LJPIRKICOISLKN-WHFBIAKZSA-N 0.000 description 2
- JLXVRFDTDUGQEE-YFKPBYRVSA-N Gly-Arg Chemical compound NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N JLXVRFDTDUGQEE-YFKPBYRVSA-N 0.000 description 2
- KKBWDNZXYLGJEY-UHFFFAOYSA-N Gly-Arg-Pro Natural products NCC(=O)NC(CCNC(=N)N)C(=O)N1CCCC1C(=O)O KKBWDNZXYLGJEY-UHFFFAOYSA-N 0.000 description 2
- XXGQRGQPGFYECI-WDSKDSINSA-N Gly-Cys-Glu Chemical compound NCC(=O)N[C@@H](CS)C(=O)N[C@H](C(O)=O)CCC(O)=O XXGQRGQPGFYECI-WDSKDSINSA-N 0.000 description 2
- JSNNHGHYGYMVCK-XVKPBYJWSA-N Gly-Glu-Val Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O JSNNHGHYGYMVCK-XVKPBYJWSA-N 0.000 description 2
- QPCVIQJVRGXUSA-LURJTMIESA-N Gly-Gly-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)CNC(=O)CN QPCVIQJVRGXUSA-LURJTMIESA-N 0.000 description 2
- YIWFXZNIBQBFHR-LURJTMIESA-N Gly-His Chemical compound [NH3+]CC(=O)N[C@H](C([O-])=O)CC1=CN=CN1 YIWFXZNIBQBFHR-LURJTMIESA-N 0.000 description 2
- NSTUFLGQJCOCDL-UWVGGRQHSA-N Gly-Leu-Arg Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N NSTUFLGQJCOCDL-UWVGGRQHSA-N 0.000 description 2
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 2
- MKIAPEZXQDILRR-YUMQZZPRSA-N Gly-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN MKIAPEZXQDILRR-YUMQZZPRSA-N 0.000 description 2
- DNAZKGFYFRGZIH-QWRGUYRKSA-N Gly-Tyr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 DNAZKGFYFRGZIH-QWRGUYRKSA-N 0.000 description 2
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 2
- WSDOHRLQDGAOGU-BQBZGAKWSA-N His-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 WSDOHRLQDGAOGU-BQBZGAKWSA-N 0.000 description 2
- KNNSUUOHFVVJOP-GUBZILKMSA-N His-Glu-Ser Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N KNNSUUOHFVVJOP-GUBZILKMSA-N 0.000 description 2
- 108010065920 Insulin Lispro Proteins 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 241000880493 Leptailurus serval Species 0.000 description 2
- KWTVLKBOQATPHJ-SRVKXCTJSA-N Leu-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(C)C)N KWTVLKBOQATPHJ-SRVKXCTJSA-N 0.000 description 2
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 2
- LXKNSJLSGPNHSK-KKUMJFAQSA-N Leu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N LXKNSJLSGPNHSK-KKUMJFAQSA-N 0.000 description 2
- ZRHDPZAAWLXXIR-SRVKXCTJSA-N Leu-Lys-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O ZRHDPZAAWLXXIR-SRVKXCTJSA-N 0.000 description 2
- JLWZLIQRYCTYBD-IHRRRGAJSA-N Leu-Lys-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JLWZLIQRYCTYBD-IHRRRGAJSA-N 0.000 description 2
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 2
- KLSUAWUZBMAZCL-RHYQMDGZSA-N Leu-Thr-Pro Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1CCC[C@H]1C(O)=O KLSUAWUZBMAZCL-RHYQMDGZSA-N 0.000 description 2
- YQFZRHYZLARWDY-IHRRRGAJSA-N Leu-Val-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN YQFZRHYZLARWDY-IHRRRGAJSA-N 0.000 description 2
- BTSXLXFPMZXVPR-DLOVCJGASA-N Lys-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCCN)N BTSXLXFPMZXVPR-DLOVCJGASA-N 0.000 description 2
- UWKNTTJNVSYXPC-CIUDSAMLSA-N Lys-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN UWKNTTJNVSYXPC-CIUDSAMLSA-N 0.000 description 2
- NQCJGQHHYZNUDK-DCAQKATOSA-N Lys-Arg-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CCCN=C(N)N NQCJGQHHYZNUDK-DCAQKATOSA-N 0.000 description 2
- HGZHSNBZDOLMLH-DCAQKATOSA-N Lys-Asn-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N HGZHSNBZDOLMLH-DCAQKATOSA-N 0.000 description 2
- PHHYNOUOUWYQRO-XIRDDKMYSA-N Lys-Asp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)N PHHYNOUOUWYQRO-XIRDDKMYSA-N 0.000 description 2
- OWRUUFUVXFREBD-KKUMJFAQSA-N Lys-His-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O OWRUUFUVXFREBD-KKUMJFAQSA-N 0.000 description 2
- ZMMDPRTXLAEMOD-BZSNNMDCSA-N Lys-His-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZMMDPRTXLAEMOD-BZSNNMDCSA-N 0.000 description 2
- MUXNCRWTWBMNHX-SRVKXCTJSA-N Lys-Leu-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O MUXNCRWTWBMNHX-SRVKXCTJSA-N 0.000 description 2
- WRODMZBHNNPRLN-SRVKXCTJSA-N Lys-Leu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O WRODMZBHNNPRLN-SRVKXCTJSA-N 0.000 description 2
- IEVXCWPVBYCJRZ-IXOXFDKPSA-N Lys-Thr-His Chemical compound NCCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 IEVXCWPVBYCJRZ-IXOXFDKPSA-N 0.000 description 2
- SQRLLZAQNOQCEG-KKUMJFAQSA-N Lys-Tyr-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CC1=CC=C(O)C=C1 SQRLLZAQNOQCEG-KKUMJFAQSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 102100024295 Maltase-glucoamylase Human genes 0.000 description 2
- XIGAHPDZLAYQOS-SRVKXCTJSA-N Met-Pro-Pro Chemical compound CSCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 XIGAHPDZLAYQOS-SRVKXCTJSA-N 0.000 description 2
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 2
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 2
- XZFYRXDAULDNFX-UHFFFAOYSA-N N-L-cysteinyl-L-phenylalanine Natural products SCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XZFYRXDAULDNFX-UHFFFAOYSA-N 0.000 description 2
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- KDYPMIZMXDECSU-JYJNAYRXSA-N Phe-Leu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 KDYPMIZMXDECSU-JYJNAYRXSA-N 0.000 description 2
- AUJWXNGCAQWLEI-KBPBESRZSA-N Phe-Lys-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O AUJWXNGCAQWLEI-KBPBESRZSA-N 0.000 description 2
- MVIJMIZJPHQGEN-IHRRRGAJSA-N Phe-Ser-Val Chemical compound CC(C)[C@@H](C([O-])=O)NC(=O)[C@H](CO)NC(=O)[C@@H]([NH3+])CC1=CC=CC=C1 MVIJMIZJPHQGEN-IHRRRGAJSA-N 0.000 description 2
- ICTZKEXYDDZZFP-SRVKXCTJSA-N Pro-Arg-Pro Chemical compound N([C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(O)=O)C(=O)[C@@H]1CCCN1 ICTZKEXYDDZZFP-SRVKXCTJSA-N 0.000 description 2
- ZCXQTRXYZOSGJR-FXQIFTODSA-N Pro-Asp-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZCXQTRXYZOSGJR-FXQIFTODSA-N 0.000 description 2
- UUHXBJHVTVGSKM-BQBZGAKWSA-N Pro-Gly-Asn Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UUHXBJHVTVGSKM-BQBZGAKWSA-N 0.000 description 2
- ZKQOUHVVXABNDG-IUCAKERBSA-N Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1 ZKQOUHVVXABNDG-IUCAKERBSA-N 0.000 description 2
- CLJLVCYFABNTHP-DCAQKATOSA-N Pro-Leu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O CLJLVCYFABNTHP-DCAQKATOSA-N 0.000 description 2
- JUJCUYWRJMFJJF-AVGNSLFASA-N Pro-Lys-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1 JUJCUYWRJMFJJF-AVGNSLFASA-N 0.000 description 2
- MHHQQZIFLWFZGR-DCAQKATOSA-N Pro-Lys-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O MHHQQZIFLWFZGR-DCAQKATOSA-N 0.000 description 2
- GOMUXSCOIWIJFP-GUBZILKMSA-N Pro-Ser-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O GOMUXSCOIWIJFP-GUBZILKMSA-N 0.000 description 2
- SXJOPONICMGFCR-DCAQKATOSA-N Pro-Ser-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O SXJOPONICMGFCR-DCAQKATOSA-N 0.000 description 2
- 108010025216 RVF peptide Proteins 0.000 description 2
- 108020003564 Retroelements Proteins 0.000 description 2
- KCFKKAQKRZBWJB-ZLUOBGJFSA-N Ser-Cys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O KCFKKAQKRZBWJB-ZLUOBGJFSA-N 0.000 description 2
- AEGUWTFAQQWVLC-BQBZGAKWSA-N Ser-Gly-Arg Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O AEGUWTFAQQWVLC-BQBZGAKWSA-N 0.000 description 2
- JFWDJFULOLKQFY-QWRGUYRKSA-N Ser-Gly-Phe Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JFWDJFULOLKQFY-QWRGUYRKSA-N 0.000 description 2
- CICQXRWZNVXFCU-SRVKXCTJSA-N Ser-His-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(C)C)C(O)=O CICQXRWZNVXFCU-SRVKXCTJSA-N 0.000 description 2
- NNFMANHDYSVNIO-DCAQKATOSA-N Ser-Lys-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NNFMANHDYSVNIO-DCAQKATOSA-N 0.000 description 2
- FPCGZYMRFFIYIH-CIUDSAMLSA-N Ser-Lys-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O FPCGZYMRFFIYIH-CIUDSAMLSA-N 0.000 description 2
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 2
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 2
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 2
- JZRYFUGREMECBH-XPUUQOCRSA-N Ser-Val-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O JZRYFUGREMECBH-XPUUQOCRSA-N 0.000 description 2
- YEDSOSIKVUMIJE-DCAQKATOSA-N Ser-Val-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O YEDSOSIKVUMIJE-DCAQKATOSA-N 0.000 description 2
- SWIKDOUVROTZCW-GCJQMDKQSA-N Thr-Asn-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C)C(=O)O)N)O SWIKDOUVROTZCW-GCJQMDKQSA-N 0.000 description 2
- ZTPXSEUVYNNZRB-CDMKHQONSA-N Thr-Gly-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ZTPXSEUVYNNZRB-CDMKHQONSA-N 0.000 description 2
- QOLYAJSZHIJCTO-VQVTYTSYSA-N Thr-Pro Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(O)=O QOLYAJSZHIJCTO-VQVTYTSYSA-N 0.000 description 2
- VUXIQSUQQYNLJP-XAVMHZPKSA-N Thr-Ser-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N)O VUXIQSUQQYNLJP-XAVMHZPKSA-N 0.000 description 2
- AOAMKFFPFOPMLX-BVSLBCMMSA-N Trp-Arg-Phe Chemical compound C([C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)N)C(O)=O)C1=CC=CC=C1 AOAMKFFPFOPMLX-BVSLBCMMSA-N 0.000 description 2
- UPUNWAXSLPBMRK-XTWBLICNSA-N Trp-Thr-Thr Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O UPUNWAXSLPBMRK-XTWBLICNSA-N 0.000 description 2
- CRCHQCUINSOGFD-JBACZVJFSA-N Trp-Tyr-Glu Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N CRCHQCUINSOGFD-JBACZVJFSA-N 0.000 description 2
- RWTFCAMQLFNPTK-UMPQAUOISA-N Trp-Val-Thr Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)=CNC2=C1 RWTFCAMQLFNPTK-UMPQAUOISA-N 0.000 description 2
- XMNDQSYABVWZRK-BZSNNMDCSA-N Tyr-Asn-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O XMNDQSYABVWZRK-BZSNNMDCSA-N 0.000 description 2
- UABYBEBXFFNCIR-YDHLFZDLSA-N Tyr-Asp-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O UABYBEBXFFNCIR-YDHLFZDLSA-N 0.000 description 2
- PMDWYLVWHRTJIW-STQMWFEESA-N Tyr-Gly-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 PMDWYLVWHRTJIW-STQMWFEESA-N 0.000 description 2
- HRHYJNLMIJWGLF-BZSNNMDCSA-N Tyr-Ser-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 HRHYJNLMIJWGLF-BZSNNMDCSA-N 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- OXGVAUFVTOPFFA-XPUUQOCRSA-N Val-Gly-Cys Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N OXGVAUFVTOPFFA-XPUUQOCRSA-N 0.000 description 2
- GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 2
- LJSZPMSUYKKKCP-UBHSHLNASA-N Val-Phe-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 LJSZPMSUYKKKCP-UBHSHLNASA-N 0.000 description 2
- PMKQKNBISAOSRI-XHSDSOJGSA-N Val-Tyr-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N PMKQKNBISAOSRI-XHSDSOJGSA-N 0.000 description 2
- IOUPEELXVYPCPG-UHFFFAOYSA-N Valylglycine Chemical compound CC(C)C(N)C(=O)NCC(O)=O IOUPEELXVYPCPG-UHFFFAOYSA-N 0.000 description 2
- 108010005233 alanylglutamic acid Proteins 0.000 description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 108010013835 arginine glutamate Proteins 0.000 description 2
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 2
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 2
- 108010038633 aspartylglutamate Proteins 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- 235000020054 awamori Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 108010013768 glutamyl-aspartyl-proline Proteins 0.000 description 2
- 108010049041 glutamylalanine Proteins 0.000 description 2
- 108010089804 glycyl-threonine Proteins 0.000 description 2
- 108010020688 glycylhistidine Proteins 0.000 description 2
- 108010015792 glycyllysine Proteins 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 108010036413 histidylglycine Proteins 0.000 description 2
- 108010025306 histidylleucine Proteins 0.000 description 2
- 108010085325 histidylproline Proteins 0.000 description 2
- 108010002685 hygromycin-B kinase Proteins 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 108010057821 leucylproline Proteins 0.000 description 2
- 108010009298 lysylglutamic acid Proteins 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 108010024607 phenylalanylalanine Proteins 0.000 description 2
- 108010012581 phenylalanylglutamate Proteins 0.000 description 2
- 108010004914 prolylarginine Proteins 0.000 description 2
- 108010070643 prolylglutamic acid Proteins 0.000 description 2
- 108010090894 prolylleucine Proteins 0.000 description 2
- 230000003362 replicative effect Effects 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 108010026333 seryl-proline Proteins 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 108010061238 threonyl-glycine Proteins 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000014621 translational initiation Effects 0.000 description 2
- 108010051110 tyrosyl-lysine Proteins 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 1
- 108091005508 Acid proteases Proteins 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- FUKFQILQFQKHLE-DCAQKATOSA-N Ala-Lys-Met Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O FUKFQILQFQKHLE-DCAQKATOSA-N 0.000 description 1
- UHFUZWSZQKMDSX-DCAQKATOSA-N Arg-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UHFUZWSZQKMDSX-DCAQKATOSA-N 0.000 description 1
- NGTYEHIRESTSRX-UWVGGRQHSA-N Arg-Lys-Gly Chemical compound NCCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N NGTYEHIRESTSRX-UWVGGRQHSA-N 0.000 description 1
- CZUHPNLXLWMYMG-UBHSHLNASA-N Arg-Phe-Ala Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 CZUHPNLXLWMYMG-UBHSHLNASA-N 0.000 description 1
- 241000228257 Aspergillus sp. Species 0.000 description 1
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 description 1
- 101100174180 Caenorhabditis elegans fos-1 gene Proteins 0.000 description 1
- 108020003215 DNA Probes Proteins 0.000 description 1
- 239000003298 DNA probe Substances 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 102000016901 Glutamate dehydrogenase Human genes 0.000 description 1
- 102100036263 Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Human genes 0.000 description 1
- 101001001786 Homo sapiens Glutamyl-tRNA(Gln) amidotransferase subunit C, mitochondrial Proteins 0.000 description 1
- 241000223200 Humicola grisea var. thermoidea Species 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 102100034343 Integrase Human genes 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- STAVRDQLZOTNKJ-RHYQMDGZSA-N Leu-Arg-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O STAVRDQLZOTNKJ-RHYQMDGZSA-N 0.000 description 1
- IWTBYNQNAPECCS-AVGNSLFASA-N Leu-Glu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 IWTBYNQNAPECCS-AVGNSLFASA-N 0.000 description 1
- REPBGZHJKYWFMJ-KKUMJFAQSA-N Leu-Lys-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N REPBGZHJKYWFMJ-KKUMJFAQSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 241000222291 Passalora fulva Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- DMEYUTSDVRCWRS-ULQDDVLXSA-N Phe-Lys-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CC=CC=C1 DMEYUTSDVRCWRS-ULQDDVLXSA-N 0.000 description 1
- 241000590419 Polygonia interrogationis Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000499912 Trichoderma reesei Species 0.000 description 1
- GWBWCGITOYODER-YTQUADARSA-N Trp-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N GWBWCGITOYODER-YTQUADARSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- AUZADXNWQMBZOO-JYJNAYRXSA-N Tyr-Pro-Arg Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CC=C(O)C=C1 AUZADXNWQMBZOO-JYJNAYRXSA-N 0.000 description 1
- UPJONISHZRADBH-XPUUQOCRSA-N Val-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(O)=O)CCC(O)=O UPJONISHZRADBH-XPUUQOCRSA-N 0.000 description 1
- BGXVHVMJZCSOCA-AVGNSLFASA-N Val-Pro-Lys Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(=O)O)N BGXVHVMJZCSOCA-AVGNSLFASA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 108010048241 acetamidase Proteins 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 101150116939 agdA gene Proteins 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 108010018691 arginyl-threonyl-arginine Proteins 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 1
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000005546 dideoxynucleotide Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000021186 dishes Nutrition 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000009585 enzyme analysis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 238000007852 inverse PCR Methods 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003471 mutagenic agent Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 244000000003 plant pathogen Species 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- VKJKEPKFPUWCAS-UHFFFAOYSA-M potassium chlorate Chemical compound [K+].[O-]Cl(=O)=O VKJKEPKFPUWCAS-UHFFFAOYSA-M 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000005204 segregation Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 101150065732 tir gene Proteins 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000005026 transcription initiation Effects 0.000 description 1
- 230000018412 transposition, RNA-mediated Effects 0.000 description 1
- 108010080629 tryptophan-leucine Proteins 0.000 description 1
- 108010071635 tyrosyl-prolyl-arginine Proteins 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
Definitions
- the present invention is directed at the identification, cloning and sequencing of mobile transposons or transposable elements from Aspergillus niger var. awamori.
- the transposable elements referred to as Vader and Tan1 , are approximately 437 base pair (bp) and 2.3 kb elements, respectively.
- the Vader and Tan1 elements are bounded by inverted repeat sequences of 44 and 45 base pairs, respectively.
- the transposable elements target a "TA" sequence in target DNA during insertion.
- the present invention is directed at the identification, cloning and sequencing of one or more transposable element(s) from other filamentous fungi using as a probe DNA comprising the Vader element 44 bp or the Tan1 element 45 bp inverted repeat isolated from Aspergillus niger var. awamori.
- Vader or Tan1 elements to inactivate genes (for example, by inserting the transposon into the gene to be inactivated), to overexpress a gene (by, for example, inserting a known promoter or other regulatory gene within the inverted repeats of Vader or Tan 1 and allowing the DNA of the IR-promoter-IR to jump in front of (and overexpress) a gene of interest) or to act as an activation marker to, for example, identify new promoters.
- transposons are a class of DNA sequences that can move from an episome to a chromosomal site or from one chromosomal site to another.
- Transposons are known in both prokaryotes, such as bacteria, as well as in eukaryotes, although there have been few transposons isolated from filamentous fungi.
- transposons in filamentous fungi.
- the element pogo which exists in multiple copies and at different sites in different strains of Neurospora crassa, was described by Schectman (1) and is believed to be a transposon.
- Schectman (1) the most characterized transposon in filamentous fungi is Tad.
- Tad was isolated as a spontaneous mutant in the am (glutamate dehydrogenase) gene in an Adiopodoume strain of N. crassa isolated from the Ivory Coast.
- Tad was a LINE-like DNA element with two major open reading frames (ORFs) on the plus strand. Typical of LINE- like elements, Tad had no terminal repeats. Attempts to isolate mobile transposons in laboratory strains of N. crassa were unsuccessful.
- a second retrotransposon was cloned by cHale et al. (5), who reported the isolation of CfT-1 , an LTR-retrotransposon from Cladosporium fulvum. This transposon was 6968 bp in length and bounded by identical long terminal repeats of 427 bp, a 5 bp target site duplication. Virus-like particles were detected which co-sediment with reverse transcriptase activity in homogenates of this fungus.
- niaD nitrate reductase
- the niaD mutants can be isolated by a direct selection for chlorate resistance (7) .
- the strategy employed was to isolate niaD mutants amongst six isolates belonging to different races of the fungus Fusarium oxysporum. More than 100 niaD mutants were isolated from each isolate and examined for instability. One strain, F24, yielded up to 10% unstable niaD mutants. Assuming that the genetic instability of the niaD mutants was caused by transposable elements, it seemed plausible that this isolate contained mobile transposons.
- a stable niaD mutant in the F24 was transformed with the cloned niaD gene from A. nidulans because the F. oxysporum niaD gene had not been cloned.
- Unstable niaD mutants were isolated in transformants containing the A. nidulans niaD gene.
- Two unstable niaD mutants were shown by Southern blot analysis to contain a insertion of 1.9 kb in size. Analysis of this element, Fort, revealed it was 1928 bp long, had a 44 bp inverted terminal repeats, contained a large open reading frame, and was flanked by a 2 bp (TA) target site duplication. Very recently, Daboussi et al.
- FML Feusarium mariner-like
- the Pot2 element duplicates the dinucleotide TA at the target insertion site. Pot2 was shown to be present at a copy number of approximately 100 per haploid genome.
- Several groups have reported looking without success for transposons in laboratory strains of A. nidulans (Kinghorn personnel communication, 5).
- One explanation for the lack of transposons in laboratory strains is that the desirable features of strain stability required for genetic analysis may preclude strains with mobile transposon.
- the niaD gene as a transposon trap we have identified and isolated a transposable element from the industrially important fungus A. niger var. awamori. This element, Vader, is present in approximately 15 copies in A. niger and A.
- novel eukaryotic transposable elements from Aspergillus niger var. awamori are provided.
- the larger transposable element, referred to herein as Tan1 is 2.3 kb in size.
- the smaller transposable element, referred to herein as Vader is a 437 bp element (SEQ ID NO:3). Vader is found within the larger element Tan1.
- the Vader transposable element is a 437 bp element which comprises a 44 bp inverted repeat sequence at either end of the transposable element.
- Tan1 is approximately a 2325 bp element which comprises 45 bp inverted repeats at either terminus and internal IRs.
- Tan1 comprises a 555 aa open reading frame (ORF) which codes for a transposase which allows the elements (Tan1 or Vader) to "hop" or insert themselves in the genome of a host.
- the target for insertion of these novel transposable elements is a "TA" sequence in the target DNA for insertion.
- the "TA” sequence is repeated at either end of the transposon upon insertion of the transposable element into the target DNA. Therefore, the present invention provides the larger Tan1 transposable element as well as the smaller element (Vader) internal thereto, as well as the DNA encoding each.
- Another embodiment of the present invention comprises a fragment of the Vader or Tan1 transposable elements which comprise the 44 or 45 bp (respectively) inverted repeat sequences found at either terminus of the transposable element from A niger var awamori, as well as the use of said fragments as probes to hybridize under low stringency conditions to DNA of other filamentous fungi for the isolating and/or cloning of transposable elements from such other filamentous fungi While the exact 44 bp IR of Vader or the 45 bp IR of Tan1 can be utilized, it is well understood by those skilled in the art that variation of such DNA would also work as a suitable probe.
- the imperfect direct repeats within the IRs of Tan1 would be suitable to use as probes for isolating transposable elements from other filamentous fungi Initially the inverted repeat of Vader was used to clone Tan1 using PCR techniques This work was followed by obtaining a genomic copy of Tan1 from a partial library.
- Another embodiment of the present invention is the transposase activity coded for by the ORF of Tan1. This transposase is 555 aa (SEQ ID NOS.7 or 14, PCR and genomic, respectively).
- transposable elements of the present invention Vader or Tan1 or any transposable element isolated using the IRs of either
- methods for gene tagging comprising using the transposable elements of the present invention (Vader or Tan1 or any transposable element isolated using the IRs of either) to inactivate genes via insertion of the element into a given gene, thus disrupting or inactivating gene expression.
- the transposable element can be used in activation tagging (to activate or turn on genes) rather than for gene disruption
- the promoter may be activated to drive the expression of the desired gene product or to turn on cryptic pathways
- gene tagging can be utilized to activate marker genes by inserting a marker gene within the IRs of a transposon of the present invention. This marker gene can then "hop" into targeted DNA and, if expression of the marker is selected for, it will be possible to identify the promoter driving such expression. This may lead to identification of isolation of new strong promoters.
- Fig. 1 shows the Southern blot analysis of unstable niaD mutants.
- PCR-amplified genomic niaD gene from four niaD mutants and UVK143f were digested with Bglll (sites are 3' of all inserts).
- Fig. 2 depicts the mapping of Vader insertions within the niaD gene.
- Fig. 3 shows Southern blot analysis to determine Vader genomic copy number.
- Four A. niger var. awamori niaD mutants and UVK143f were digested with EcoRV to completion. EcoRV cuts the Vader sequence once. Hybridization indicates that Vader is present in the genome in more than 14 copies.
- Fig. 4 Southern blot to determine presence of Vader sequence in other fungi.
- Other filamentous fungi, an industrial production strain and niaD mutant 392 were digested with EcoRV to completion.
- Low stringency hybridization (32) indicates that sequences homologous to Vader are present in A. nidulans (FGSC A237), A. cinnamomeus, A. phoenicis, A. foetidus, an industrial A. niger strain.
- Fig. 7 shows the sequence of the Vader insertion (SEQ ID NO:3) as generated by PCR. Vader was found to be 437 bp in length. The 44 bp inverted repeat of the Vader insert corresponding to SEQ ID NO:4 (the 5' IR) and SEQ ID NO:5 (the 3' IR), respectively, from the 5' end to the 3' end of Vader are underlined, the single mismatch which occurs in the inverted repeats is identified in bold, and the TA 2 bp duplication is shown in bold print. niaD sequences flanking the element are shown in lower case letters.
- Figs. 8A and 8D show the entire DNA sequence of the Tani element (SEQ ID NO:6) as generated by PCR, as well as the putative amino acid sequence of the transposase coded for by Tani (SEQ ID NO:7).
- Tani as generated by PCR is 2320 bp in length (excluding the unknown nucleotides shown as "N" in the figure) and has a large open reading frame of 1668 bp which encodes for 555 amino acids (SEQ ID NO:7). Tani comprises the sequences of four inverted repeats (underlined) similar to those found in Vader.
- Fig. 9 shows a schematic presentation of Vader and Tani elements.
- Fig. 10 shows Southern analysis of A. niger var.
- awamori niaD mutants (/7/aD410, n/ ' aD436, niaD587, niaD392) and the wild-type UVK143f: lane 1 , molecular weight marker III (Boehringer Mannheim); lane 2, UVK143f; lane 3, n/aD410; lane 4, n/a0436; lane 5, niaD5- 87; lane 6, niaD3Q2.
- This blot was probed for the Vader element (see Fig. 9).
- this blot (Fig. 10) was superimposed with the blot shown in Fig. 5, one of the illuminated bands from the Vader-probe hybridization overlaid the single band in the ORF-probe hybridization indicating that the Tani element is composed of contiguous ORF and Vader elements.
- Figs. 11A and 11D show the nucleotide sequence (genomic copy) of Tani (SEQ ID NO: 13).
- the amino acid sequence encoding the putative transposase (555 aa) (SEQ ID NO: 14) is shown below the DNA sequence in the one-letter amino acid code.
- the inverted repeats are underlined (SEQ ID NOS:1, 2, 15 and 16, respectively, 5' to 3') and the imperfect direct repeats within the inverted repeats are shown with arrows above or below the sequence.
- the gaps within the arrows indicate the imperfect nucleotides within the direct repeats.
- Undetermined sequence is denoted in the figure by question marks and in the sequence listing as "N.”
- the figure shows the DNA sequence as 2324 base pairs, excluding the unknown nucleotides indicated by "?” in the figure.
- nucleotide bases are designated as adenine (A); thymine (T); guanine (G) ; and cytosine (C).
- A adenine
- T thymine
- G guanine
- C cytosine
- Applicants have isolated two transposable elements from A niger var. awamori.
- the cloned element Vader was identified by screening unstable nitrate reductase (niaD) mutants for insertion. This element is present in approximately fifteen copies in the genome of A. niger strains examined. In contrast, the Vader element is present in one copy in only one of the two A. nidulans strains studied.
- the Vader element shows similarities to transposable elements cloned from the plant pathogens Pot1 from M. grisea (12) and Fot1 from F. oxysporum (8).
- the target site for duplication in all three fungi is a 2 bp TA sequence.
- Fot1 this transposon does not excise precisely.
- the excision products retained a 4 bp insertion relative to the wild-type gene (TAATTA versus TA).
- the insertion studied was integrated into an intron, therefore, imprecise excision of Fot1 did not effect the functionality of the niaD gene product.
- Pot2 is a functional element.
- a homology search made at the nucleotide level gave a strong 60.7% homology between Tani and a 1230 bp overlap to the A. oryzae agdA gene coding for an ⁇ - glucosidase (33).
- This homology search revealed that the last 1.2 kb of a total of 5.2 kb of the ⁇ -glucosidase sequence submitted to GenBank is, in fact, part of a novel transposon, hereinafter called Tao1 (transposon Aspergillus oryzae), which also belongs to the Fot1 family. Only the 5' half of the Tao1 element is included in the GenBank sequence, thus, for the lack of comparison, the exact size of the inverted repeat cannot be determined.
- Tao1 would hybridize to a probe comprising Tani or Vader IRs or variations thereof.
- the sequence of the IR of Tao1 is provided as SEQ ID NO:17.
- This IR (Tao1) or the IRs from Tani or Vader may be used to isolate other transposable elements from filamentous fungi.
- elements which transpose directly through DNA copies are typified by having inverted terminal repeats.
- Elements which transpose through reinsertion of the product of reverse transcription of an RNA copy of the element can be without long terminal repeats such as the Drosphilia I element (for a review see (16)).
- retrotransposons can have long terminal repeats such as the Drosphilia copia element.
- Elements which transpose through DNA copies typically have open reading frame(s) which encode a transposase activity.
- the Fot1 element is 1.9 kb in length and the Pot1 element 1.8 kb in length Both the Fot1 and Pot1 elements have ORF encoding for a putative transposase-like protein
- the Vader element although mobile, does not have an ORF and hence it was deduced that the mobility of Vader was dependent upon a transposase activity present elsewhere in the genome.
- a synthetic 44 bp oligomer of the inverted repeat of Vader (SEQ ID NO:5) was used to clone, via PCR, a 2.3 kb element
- Tani This element, called Tani (SEQ ID NO:6), compnses four inverted repeats (SEQ ID NOS:1, 2, 15 and 16 from 5' to 3', respectively) similar to those in Vader and has a unique organization IR-ORF-IR-IR-Vader-IR Tani is 2324 bp in length and has a large open reading frame (1668 bp) which encodes a putative transposase comprising 555 amino acids (shown in SEQ ID NOS 7 and 14), which is homologous to Fot1 and Pot2 transposases Immediately 3' to the second IR (SEQ ID NO:2), which bounds the transposase, is a copy of the Vader element.
- transposable element(s) with certain Aspergillus species
- transposable elements are believed to be quite useful in the development of gene tagging systems for Aspergillus or other microorganisms
- Basic requirements for developing a gene tagging system are that the tagging element can be distinguished from the endogenous elements, it displays little sequence specificity for transposition and that excision is followed by integration at a new site
- More refined tagging systems include ability to monitor excision and reinsertion by, e.g., activation of antibiotic resistance genes and ability to stabilize the mutations by, e g., a two transposons system (23, 24 and 25).
- a first vector can be constructed for expression of the Vader element, similar to the non-autonomous maize Dc
- the internal sequence of the Vader element is altered to contain translation initiation and stop codons in three different frames This sequence can later be used as a recognition site for a probe in PCR analysis of the mutants.
- This altered Vader element, Vader-S is inserted within an expression cassette conferring antibiotic resistance such as hygromycin resistance. Since excision of Vader may not always be precise, Vader-S is inserted in the promoter area (e.g., o//C) between the transcription and translation initiation sites.
- This disrupted hygromycin phosphotransferase cassette is flanked by marker genes - or alternatively the marker gene upstream of the hygromycin promoter can be placed within Vader. These marker genes can be used for monitoring whether the hygromycin gene, and Vader within it, have integrated in full length.
- a vector, for example, Vector I containing these elements will be transferred to A. nidulans and transformants expressing the two marker genes, but sensitive to hygromycin, are selected. Screening of mutants at later stages is easier, if the transformant selected for mutagenesis has only one to two copies of Vector I sequences integrated in its genome.
- a transformant with only a few (preferentially one) intact Vader-S/hygromycin phosphotransferase cassettes integrated in its genome is retransformed with Vector II, which is an autonomously replicating vector carrying the transposase encoding gene.
- the autonomously replicating vector, pHELP used as a basis for DNA construction work, can be segregated away by methods known to those skilled in the art. This enables stabilization of the Vader-S element after the mutagenesis step.
- Vader-S is activated by a transposase (from Tani) in pHELP, which can be monitored by activation of the hygromycin resistance gene. Tani is not cloned into the vector in full length to disrupt its mobility.
- Vector II contains a marker gene used for screening of transformants and also for monitoring its segregation after the sporulation phase.
- Marker genes can either complement host mutations or be dominant markers such as benomyl R , acetamidase or ⁇ -glucuronidase (GUS).
- GUS ⁇ -glucuronidase
- the target gene for mutagenesis should be one with a simple plate screen, e.g., disruption of the niaD gene (by insertion of Vader), which can be screened by selection of chlorate resistant mutants and the gene disruption can be further mapped by a plate test using different nitrogen sources (no growth on nitrate, growth on nitrite, xanthine and uric acid).
- Another target gene for mutagenesis could be an acid protease gene. It has been shown previously for A. niger that disruption of this one protease is sufficient to abolish halo formation almost completely on skim milk plates.
- transposon tagging is that the mutants produced can be identified by subsequent isolation of the mutated gene.
- PCR methods developed for genomic walking are, e.g., “Inverse PCR” (27 and 28), “Vectorette PCR” (29) and “Panhandle PCR” (30).
- transposon tagging system Setting up the transposon tagging system can be followed by studies of excision frequency, environmental influences on transposition frequency (24, 31), activation of the transposase by a heterologous promoter and effect of altered inverted repeats on transposition.
- Transposon tagging does need to be applied for inactivation of genes.
- tagging can be used to insert promoter sequences in Vader and therein activate genes.
- a third option is to insert a promoterless marker gene in Vader, in which case the transposon can be used in search for novel, strong fungal promoters.
- Vader and Tani elements were isolated from Aspergillus niger var. awamori UVK143f, derived from Northern Regional Research Laboratories (NRRL) #3112.
- E. co// JM101 [F' traD36 lacf A(lacZ)M15 proA * B * IsupE thi A(lac-proAB)] and Epicurian coli SURE 2 (Stratagene Cloning Systems, La Jolla, CA) were used for propagation of Vader and Tani subclones, respectively.
- Spontaneous chlorate resistant mutants were derived from Aspergillus niger var. awamori UVK143f (NRRL #3112).
- the following Aspergillus strains were obtained from the ATCC: A. cinnamomeus (ATCC #1027), A. wentii (ATCC #10593), and A. phoenicis (ATCC #11362).
- A. nidulans (FGSC #A237), a nitrate reductase structural gene mutant (n/aD15), and A. nidulans (FGSC #A691), a tryptophan requiring mutant (rrpC801), were obtained from Fungal Genetics Stock Center (FGSC), Dept. of Microbiology, University of Kansas Medical Center.
- A. versicolor, A. foetidus, and a proprietary A. niger glucoamylase strain are from the Genencor International Inc. culture collection. p
- niaD mutants Single mutants resistant to KCIO 3 were allowed to sporulate on CM plates and spores from these plates were then streaked onto minimal media (11) with various sole nitrogen sources (10 mM): NaNO 3 (nitrate), NaNO 2 (nitrite), hypoxanthine, uric acid or NH 4 CI (ammonium chloride). Each of these compounds are intermediate products of the nitrate assimilation pathway. niaD mutants were identified as those resistant to KCIO 3 and able to grow in the presence of all pathway intermediates, except for NaNO 3 .
- the reaction mixture contained 4 mM MgSO 4 .
- Denaturation of template DNA 2 min. at 94°C, was followed by 30 cycles of denaturation (30 sec. at 94°C), annealing of primers (45 sec. at 55°C) and extension (4 min. at 72°C).
- PCR fragments were purified from gel using the Qiaex DNA gel extraction kit (Qiagen), digested and used for restriction enzyme analysis by standard procedures (12). Confirmation of Excision Foot Print by PCR Amplification and Sequencing.
- Template DNA from n/aD436 was used in a PCR reaction in an attempt to amplify both the larger niaD sequence with an insert and the shorter niaD fragment resulting from excision of the Vader element.
- the PCR reaction was conducted as previously described, except for using primers MA003 (positions 359-378): 5'- ATATGAATTCCTTCTTGACTTCCCCGGAAC-3' (SEQ ID NO:11) and NiaD5 (position
- Deep Vent (exo " ) DNA polymerase (New England Biolabs) was used with the buffer and dNTPs provided by the manufacturer. Denaturation of template DNA, 10 min. at 94°C, was followed by 30 cycles of denaturation (1 min. at 94°C), annealing of primers (1 min. at 55°C) and extension (6 min. at 72°C). PCR fragments were purified from agarose gels using the Qiaex DNA gel extraction kit (Qiagen) and subcloned as blunt-ended inserts into EcoRV cut pSL1180 (Pharmacia Biotech).
- niaD Mutant Reversion Frequency Spores from niaD mutants n/aD392, ⁇ /aD410, n/aD436 and niaD587 were streaked onto minimal media containing NaNO 3 as a sole nitrogen source. Nitrate non-utilizing colonies of niaD mutants, which had a spidery appearance and did not sporulate, were streaked onto CM containing 600 mM potassium chlorate (KCIO 3 ) and incubated to confluency at 37°C.
- KCIO 3 600 mM potassium chlorate
- Genomic DNA for PCR and Southern analysis was isolated (13) from mycelia grown in CSL (13), which contained 600 mM KCIO 3 in order to reduce reversion of niaD back to the wild-type during cultivation.
- DNA (10 ⁇ g) was digested with either Bglll, which leaves the insertion intact in the niaD gene, or with EcoRV, which cuts the insertion element (Vader) once, and thus enables determination of its copy number in the genome.
- Genomic DNA (approximately 10 ⁇ g) of A. nidulans, A. cinnamomeus, A. versicolor, A. wentii, A. phoenicis, A. foetidus and of an industrial A.
- niger strain were digested with EcoRV to obtain an estimate of Vader copy number in these fungal genomes.
- the digested and gel-separated DNA was transferred to a positively-charged nylon membrane (Boehringer Mannheim) by capillary action.
- the DNA probe for the niaD gene was derived from the PCR product (UVK143f DNA template amplified with primers NiaD1 (SEQ ID NO:8) and NiaD2 (SEQ ID NO:9)), which was digested with Sail, resulting in a 528 bp probe fragment.
- the probe for the insertion element, Vader was derived from a PCR reaction in which n aD436 DNA was used as a template. This PCR product was purified and digested with Sail and SphI and subcloned into the vector pUC19. This subclone was digested with Seal and Xbal to yield a 236 bp fragment which was used for estimation of the copy number of Vader sequences in the genomes of various fungi.
- a DNA labeling and detection kit (Genius 1 , Boehringer Mannheim) was used for random primed labeling of probe DNA with digoxigenin, and for detection with alkaline- phosphatase labeled antibody to digoxigenin.
- Hybridization and washing conditions for homologous probes were conducted as recommended by the manufacturer using hybridization buffer without formamide at 68°C (Boehringer Mannheim).
- Hybridizations for heterologous Southern analysis i.e., analysis of DNA from other Aspergillus sp. was conducted using hybridization buffer with 25% formamide at 37°C. Washes were performed as in stringent wash protocol.
- Nitrate Reductase Assays Nitrate reductase assays were performed as described in Dunn-Coleman, et al. (18). DNA Analysis and Sequence Determination. Sequences were determined using fluorescent-labeled dideoxynucleotide terminators and Taq cycle sequencing on the 373A sequencer (ABI). Commercially available universal and reverse (New England Biolabs) primers were used. Alignment of sequences and prediction of amino acid sequences were performed using DNASTAR (DNASTAR, Inc.). The nucleotide and deduced amino acid sequences were analyzed and compared to those in GenBank, EMBL and Prot-Swiss using Fast A and BLAST programs (Genetics Computer Group, Inc. software package, Madison, Wl).
- the Tani probe was prepared by digesting Tani with HindlW and Stu ⁇ resulting in a 650 bp fragment corresponding to the 3' end of the transposase coding region (ORF-probe in Fig. 9).
- the Vader element was digested with Xba ⁇ and Seal to yield a 236 bp fragment to be used for recognition of internal Vader sequence in Southern analysis (Vader-probe in Fig. 9).
- niaD mutants which arise from the insertion of a transposable element would be unstable
- a total of 152 niaD mutants, isolated on the basis of spontaneous resistance to chlorate were characterized.
- spores from 43 niaD mutants were plated onto medium with nitrate as the sole nitrogen source. Fourteen of the mutants reverted to the wild-type phenotype at a frequency of greater than 1 X 10 5.
- Table 1 summarizes the niaD mutant reversion studies.
- niaD mutants There appeared to be two classes of niaD mutants which reverted at high frequency.
- the niaD mutants rw ' aD436 and niaD392 reverted at high frequency, while mutants n/aD410 and niaD587 yielded smaller numbers of revertant colonies.
- nitrate reductase activity was determined using the assay described in (18) from revertant colonies isolated from the niaD 436 mutant. Nitrate reductase activity was detected in 14 of 15 revertants analyzed (see Table 2). A spectrum of activities was detected, suggesting that excision of Vader may not always be precise.
- UVK143f wild-type 100 niaD436 (niaD mutant) ND 1
- niaDI SEQ ID NO:8
- niaD2 SEQ ID NO:9
- Genomic DNA was isolated from 14 unstable niaD mutants. This genomic DNA served as a template for the PCR primers.
- PCR reaction products with 4 niaD mutants revealed an approximately 440 bp insertion (Vader) in the niaD gene.
- genomic DNA isolated from the wild-type and four niaD mutants (410, 436, 587 and 392) was digested with Bglll.
- the probe used was a Sail digestion fragment of the 500 bp PCR product generated using the niaDI (SEQ ID NO:8) and niaD2 (SEQ ID NO:9) oligomeric probes.
- the probe hybridized to a 2.5 kb fragment with wild-type DNA (lane 5, Fig. 1).
- the niaD mutants 410 (lane 1 , Fig. 1), 436(lane 3, Fig. 1) and 392 (lane 4, Fig.
- Vader Copy Number To determine the Vader copy number a 236 bp Scal-Xbal internal fragment of Vader-2 (cloned from the mutant n/aD436) was hybridized to EcoRV cleaved genomic DNA. There is only one EcoRV site within the Vader transposon. Southern blot analysis indicated that there are approximately fifteen copies of Vader sequences in the genome of A. niger var. awamori. (Fig. 4). The Vader sequences were integrated at identical genomic locations in the three niaD mutants, 410, 436 and 587. However, in the n/aD392 mutant, Vader sequences were located in five different locations compared to the three niaD mutants examined.
- Example 4 Isolation of Vader in Other Fungal Species
- genomic Southern blot analysis was performed using the 236 bp fragment (Xbal-Scal) of Vader sequence as per Example 3, as a probe (Fig. 5).
- Two strains of A. nidulans were obtained from Fungal Genetics Stock Center (FGSC), FGSC #A691, a nitrate reductase structural gene mutant ( ⁇ /aD15), and FGSC #A237, a tryptophan-requiring mutant ( rpC801). No hybridization signals could be visualized with strain A691, and a single strong hybridization signal could be detected with strain A237.
- Example 6 Isolation of Tani
- the previously isolated Vader element although mobile, did not have an ORF encoding transposase activity presumed to be required for excision (22). This observation led to a search for a transposase-encoding larger element, thus an oligomer corresponding to the Vader inverted repeat was synthesized and used for PCR amplification of the genomic A. niger var. awamori DNA.
- the PCR amplification resulted in the generation of three DNA fragments: the 0.4 kb Vader element, as expected, and fragments of 1.9 kb and 2.3 kb in length.
- the larger 2.3 kb fragment had a unique organization, IR-ORF-IR-IR-Vader-IR, with a total of four inverted repeats (Figs. 9 and 11).
- the two central inverted repeats side by side, potentially form a tight hairpin structure, and despite many sequencing attempts with varying conditions, we were unable to determine the sequence between the two inverted repeats.
- the overall length of the PCR product as determined by electrophoresis, corresponded to the size of the sequence shown in Fig. 11 , suggesting that the two central contiguous IRs are not separated by a large segment of DNA.
- niger var. awamori niaD mutants and UVK143f were digested with EcoRI, which cuts once in the coding region of the ORF upstream from the ORF-probe and does not cut Vader.
- the Southern analysis showed numerous bands for the Vader element (Fig. 10), similar to previous Southern analyses (22). However, only one fragment lit up with the probe corresponding to the ORF and a fragment of the same size (1.6 kb) was recognized by the Vader probe (Fig. 10). It was concluded that the actual element in the genome was the 2.3 kb fragment and that the shorter 1.9 kb had only been a PCR-artifact. The isolated 2.3 kb fragment was designated as Tani.
- a genomic clone of the Tani element (2.3 kb) was isolated from a partial genomic library. Restriction enzymes, which were shown not to have any recognition sites in the PCR-amplified Tani , were used separately and in combinations in Southern analysis of the genomic DNA. A double digestion with BglW and Xhol resulted in a relatively short, 4.5 kb, fragment which hybridized with the ORF-specific probe (data not shown). Genomic DNA fragments cleaved by BglU and Xhol and between 4 kb and 5 kb in size were cloned into pSP73 (Promega). The correct clone containing the Tani element was isolated by colony hybridization using the ORF-specific probe.
- Vader was cloned by insertional inactivation of the target gene niaD, which encodes nitrate reductase.
- the target sequence for integration of Vader is TA, a sequence which must be very common in the genome of fungi.
- Nitrate reductase mutants cannot grow on nitrate and inconsequence are resistant to the toxic analog of nitrate, KCIO 3 . It is possible that one of the reasons heterologous protein production in fungi is lower than that of homologously produced protein using the same promoter is that the heterologous protein is being degraded by the cell. If there are genes whose products are responsible for degrading/sequestering foreign protein, it would be advantageous to inactivate those genes.
- a strain is constructed using gene disruption, which lacks the Tani gene. Such strain is then used to transform and express a heterologous protein such as the mammalian chymosin protein. It would be advantageous if the activity of such genes could be visualized or selected for on petri dishes. For example chymosin produced in A. niger results in a halo of clearing around a colony grown on skim milk. (See US Patent 5,364,770, the disclosure of which is incorporated herein by reference.)
- the transformants are then plated on medium which can be used to visualize heterologous protein production, such as skim milk plates in the case of chymosin.
- the plates are then screened for increased halo size, which is the result of inactivation of a gene whose product limits foreign protein production.
- the inactivated gene can be cloned using the transposon sequences as a marker for cloning strategies. (See generally (19).)
- Example 8 Elevation of Gene Expression Using Transposons A reason that heterologous protein production is lower than expected in fungi is presumed to be that genes essential for foreign (heterologous) gene production are NOT expressed at sufficiently high levels in the fungi.
- a strain is constructed in which the native Tani gene is inactivated by gene disruption.
- This strain is used to express a heterologous protein whose expression can be easily visualized, such as chymosin (US Patent 5,364,770).
- a second transformation is made with Vader and Tani , appropriately modified for gene tagging purposes.
- the internal sequence of Vader is replaced by a promoter sequence.
- One of the many integration events possible will be the integration of this promoter carrying Vader element into 5' to a gene beneficial to heterologous protein (e.g., chymosin) expression or secretion.
- this beneficial gene is activated and such integrant colonies can be screened for, e.g., increased halo size (chymosin).
- the activated gene can be cloned using the transposon sequences as a marker for cloning strategies.
- MOLECULE TYPE DNA
- SEQUENCE DESCRIPTION SEQ ID NO: 5:
- ATCAAAGTCG AATATAATCA GTGGTTTTAG AGCAACAGGT CTTGTTCCTC TAGATCCTGA 1260
- MOLECULE TYPE DNA (genomic)
- ATCAAAGTCG AATATAATCA GTGGTTTTAG AGCAACAGGT CTTGTTCCTC TAGATCCTGA 1260
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US703077 | 1991-05-20 | ||
| US70307796A | 1996-08-26 | 1996-08-26 | |
| PCT/US1997/014978 WO1998008960A1 (fr) | 1996-08-26 | 1997-08-25 | IDENTIFICATION ET CLONAGE D'UN TRANSPOSON MOBILE ISSU D'$i(ASPERGILLUS) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP0920521A1 true EP0920521A1 (fr) | 1999-06-09 |
Family
ID=24823898
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP97939558A Withdrawn EP0920521A1 (fr) | 1996-08-26 | 1997-08-25 | IDENTIFICATION ET CLONAGE D'UN TRANSPOSON MOBILE ISSU D'$i(ASPERGILLUS) |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP0920521A1 (fr) |
| CA (1) | CA2262519A1 (fr) |
| WO (1) | WO1998008960A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2355459B (en) | 1999-11-29 | 2001-09-26 | Isis Innovation | A dominant conditional lethal genetic system |
| GB2402675B (en) * | 2003-05-12 | 2008-02-20 | Oxitec Ltd | Resistance dilution |
| GB2403475B (en) | 2003-07-01 | 2008-02-06 | Oxitec Ltd | Stable integrands |
| GB2441249B (en) * | 2003-07-01 | 2008-04-09 | Oxitec Ltd | Stable integrands |
| GB2404382B (en) | 2003-07-28 | 2008-01-30 | Oxitec Ltd | Pest control |
| GB0404433D0 (en) * | 2004-02-27 | 2004-03-31 | F2G Ltd | Transposon mutagenesis |
| GB2443186A (en) | 2006-10-25 | 2008-04-30 | Oxitec Ltd | Expression system for mediating alternative splicing |
| GB2500113A (en) | 2012-03-05 | 2013-09-11 | Oxitec Ltd | Arthropod male germline gene expression system |
| GB201303932D0 (en) | 2013-03-05 | 2013-04-17 | Oxitec Ltd | Muscle actin promoter |
| GB2526867A (en) | 2014-06-05 | 2015-12-09 | Oxitec Ltd | Gene expression system |
| WO2018029534A1 (fr) | 2016-08-12 | 2018-02-15 | Oxitec Ltd. | Gène spécifique du sexe à auto-limitation et procédés d'utilisation |
| AR117409A1 (es) | 2018-03-29 | 2021-08-04 | Oxitec Ltd | Noctuidas autolimitantes |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4128619B2 (ja) * | 1995-03-21 | 2008-07-30 | ジェネンコア インターナショナル インコーポレーテッド | アスペルギルス(Aspergillus)属由来の可動性トランスポゾンの同定およびクローニング |
-
1997
- 1997-08-25 CA CA002262519A patent/CA2262519A1/fr not_active Abandoned
- 1997-08-25 EP EP97939558A patent/EP0920521A1/fr not_active Withdrawn
- 1997-08-25 WO PCT/US1997/014978 patent/WO1998008960A1/fr not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| See references of WO9808960A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998008960A1 (fr) | 1998-03-05 |
| CA2262519A1 (fr) | 1998-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kahmann et al. | REMI (restriction enzyme mediated integration) and its impact on the isolation of pathogenicity genes in fungi attacking plants | |
| US4880741A (en) | Process for transformation of Yarrowia lipolytica | |
| EP1321523A2 (fr) | Souches récombinantes dépourvues de marqueurs de sélection: procédé pour leur obtention et utilisation de ces souches | |
| JP4563585B2 (ja) | ポリペプチドの生成方法において有用な菌類転写活性化因子 | |
| EP0920521A1 (fr) | IDENTIFICATION ET CLONAGE D'UN TRANSPOSON MOBILE ISSU D'$i(ASPERGILLUS) | |
| EP0138508B1 (fr) | Procédé pour la transformation de yarrowia lipolytica | |
| Walz et al. | Transformation of Sordaria macrospora to hygromycin B resistance: characterization of transformants by electrophoretic karyotyping and tetrad analysis | |
| Amutan et al. | Identification and cloning of a mobile transposon from Aspergillus niger var. awamori | |
| US7501275B2 (en) | Yeast transformation system | |
| JP2011087596A (ja) | マグナポルセにおける機能的遺伝子とインパラトランスポゾンとを含む、真菌における突然変異誘発用のポリヌクレオチド | |
| Gonzalez et al. | Transformation of the dermatophyte Trichophyton mentagrophytes to hygromycin B resistance | |
| EP0866129A2 (fr) | Séquences d'ADN génomiques de Ashbya gossypii et leurs utilisations | |
| US4628033A (en) | Novel host strain for transformation of Yarrowia lipolytica | |
| EP0549062B1 (fr) | Système d'expression eucaryote | |
| US5985570A (en) | Identification of and cloning a mobile transposon from Aspergillus | |
| CA2215799C (fr) | Identification et clonage d'un transposon mobile a partir d'aspergillus | |
| Ding et al. | Global control of meiotic recombination genes by Schizosaccharomyces pombe rec16 (rep1) | |
| EP0173668B2 (fr) | Saccharomycète recombinant | |
| JP4330452B2 (ja) | 選択マーカー遺伝子 | |
| EP1801221A1 (fr) | Sequences de promoteurs | |
| JP3945866B2 (ja) | メタノール酵母由来のプロテインジスルフィドイソメラーゼ遺伝子 | |
| JP2008532535A (ja) | 宿主細胞における改善された発現クローニング法 | |
| Whitehead | Development of homologous transformation systems for the filamentous fungi'Cephalosporium acremonium'and'Penicillium chrysogenum' | |
| NEITZ | CENTROMERE STRUCTURE AND FUNCTION IN SACCHAROMYCES CEREVISIAE (YEAST, CEN, RECOMBINATION) | |
| JPH0568569A (ja) | エンドチアペプシン前駆体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19990226 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE |
|
| RTI1 | Title (correction) |
Free format text: IDENTIFICATION OF AND CLONING A MOBILE TRANSPOSON FROM ASPERGILLUS |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: GENENCOR INTERNATIONAL, INC. |
|
| 17Q | First examination report despatched |
Effective date: 20021105 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20030516 |